The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

Registration

We are not accepting online registrations for this event at this time. For more information, please contact IBC Customer Service by email at reg@ibcusa.com or by phone at 800-390-4078 or US +1 941-554-3500.
Register Now!

Download Brochure

Download Brochure
Full Conference Details Inside

Event Information

Related Events

Find Another IBC Event

TIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

CSS

Access the hottest fields in therapeutics by attending TIDES - the only event with full coverage of discovery, development and manufacturing

May 20-23, 2012 · Mandalay Bay Resort & Casino · Las Vegas, NV

Alt Language

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Agenda Overview

Agenda Overview

Sunday, May 20, 2012
9:00 am - 1:00 pm Course #1: Business and Operational Strategies for Successful Oligonucleotide Development Course #2: Peptide Manufacturing and Analysis: A Basic Tutorial Course #3: Early Drug Product Development
2:00 pm - 3:30 pm Course #4: Peptide-Oligonucleotide Conjugation Strategies
4:00 pm - 6:00 pm Special Event: CMO-Sponsor Relationships in Therapeutic Development - Expectations and Realities
(Open to all TIDES main conference attendees)
6:00 pm - 7:30 pm Welcoming Reception for Course Attendees
Co-Sponsored by: Avecia and IBC Life Sciences
Monday, May 21, 2012
Poster and Exhibit Hall Hours: 3:15 pm - 7:15 pm
8:45 am - 12:30 pm

Keynote Presentations:

  • Therapeutic Oligonucleotide Development: A Promising Outlook
  • Resources to Enable and Facilitate siRNA Drug Development in China
  • Harnessing the "New" Endocrinology of Peptide Hormones - Discovery of Novel Therapies Targeting Metabolic Disease
  • RaPID Discovery of Natural Product-Like Peptides against Therapeutic Targets
1:45 pm - 3:15 pmPlenary Session
3:15 pmOpening of Poster and Exhibit Hall with Networking Refreshment Break
3:55 pm - 6:00 pmPlenary Session
6:00 pm - 7:15 pmNetworking Reception in Poster and Exhibit Hall
Tuesday, May 22, 2012
Poster and Exhibit Hall Hours: 10:30 am - 6:30 pm
  Manufacturing & Product Development Oligonucleotide Therapeutics Discovery Peptide Discovery and Development Nucleic Acids Technologies for Molecular Diagnostics
  Oligonucleotides Peptides
8:15 am - 10:30 am CMC Challenges and Solutions
Sponsored by Avecia		 Oligonucleotide Delivery: Mechanisms, Cellular Barriers and Cell/Tissue Targeting Cell-Penetrating Peptides with Intrinsic Functional Activity: New Targets and Disease Mechanisms

Keynote Presentation:
Update on Commercialization of RUO and IUO Products and Oversight of Lab-Developed Tests

Regulatory Pathways and Quality Strategies
11:15 am - 12:45 pm Strategy Discussion Forum: Quality by Design - Revisited
Sponsored by Avecia		 Strategy Discussion Forum: When to Choose Recombinant vs. Synthetic Production of Peptides: The Complexities of a "Simple" Decision Spotlight Presentations
Sponsored by GE Healthcare, Peptisynth, and Sekisui 		Oligonucleotide Delivery: Mechanisms, Cellular Barriers and Cell/Tissue Targeting Innovations in Cell-Penetrating and Membrane-Permeating Peptides
12:45 pm - 1:50 pmNetworking Luncheon in Poster and Exhibit Hall Sponsored by Lonza
1:55 pm - 3:30 pm CMC Challenges and Solutions
Sponsored by Avecia		 CMC Challenges and Solutions
Sponsored by Bachem		 New Data from Oligonucleotides in Development Innovations in Cell-Penetrating and Membrane-Permeating Peptides Peptide Generation, Lead Optimization and Candidate Selection Analytical Methods and Validation
4:00 pm - 5:30 pm

Strategy Discussion Forum: The Oligo Supply Chain: How Strong is the Weakest Link? Sponsored by Agilent Technologies

Emerging Technologies Spotlight Presentations Sponsored by Agilent Technologies, BioSpring GmbH, and ST Pharma

 Emerging Technologies Spotlight Presentations Sponsored by Ajinomoto and Unigene Laboratories
5:30 pm - 6:30 pmNetworking Reception and Booth Crawl in Poster and Exhibit Hall with Dedicated Poster Viewing
Wednesday, May 23, 2012
Poster and Exhibit Hall Hours: 10:30 am - 2:00 pm
  Manufacturing & Product Development Oligonucleotide Therapeutics Discovery Peptide Discovery and Development Nucleic Acids Technologies for Molecular Diagnostics
  Oligonucleotides Peptides
8:25 am - 10:30 am Early Drug Product Development for Oligos and Peptides Preclinical Chemical Modifications to Improve Drug-Like Properties Novel Peptide-Like Scaffolds and Peptide Discovery

Keynote Presentation: The Next Generation in Clinical Molecular Diagnostics

Manufacturing and Business Considerations for Successful Launch in Clinical Market
11:15 am - 12:45 pm

Strategy Discussion Forum: Impurities: At What Stage do you Need to Qualify Impurities

Strategy Discussion Forum: Preclinical Evaluation of Immunomodulatory Effects of Oligonucleotides and Formulations: Challenges and Strategies

 Strategy Discussion Forum: Strategies for Formulation Transition Emerging Preclinical and Clinical Results New Approaches to Making Drug-Like Peptides
12:45 pm - 1:55 pmNetworking Luncheon, Exhibit and Poster Viewing in Exhibit Hall
1:50 pm - 3:30 pm CMC Aspects of Alternative Delivery Routes CMC Aspects of Alternative Delivery Routes Emerging Preclinical and Clinical Results

New Approaches to Making Drug-Like Peptides

Creative Strategies to Improve Peptide Drug Discovery and Expand Target Space

 New Technologies
4:00 pm - 5:30 pm Strategy Discussion Forum: Alternative Delivery Platforms for Oligonucleotide and Peptide Therapeutics Strategy Discussion Forum: Conjugation: From a One-Off Approach to a Platform Technology - Pros and Cons
5:30 pmClose of Conference